newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting

Annual Meeting Reconvened and Adjourned Without Conducting Business Meeting to Reconvene on July 27, 2023 at 9:00 am EDT DEVON, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) (the